» Articles » PMID: 35268329

Inter-Eye Comparison of the Ocular Surface of Glaucoma Patients Receiving Surgical and Medical Treatments

Overview
Journal J Clin Med
Specialty General Medicine
Date 2022 Mar 10
PMID 35268329
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ocular surface frequently affects glaucoma patients. In this paper we aimed at evaluating the impact of glaucoma surgery on the ocular surface of patients who received unilateral trabeculectomy. Methods: 26 consecutive patients successfully treated with trabeculectomy on one eye (Trab Eye) and under control with topical treatments on the fellow eye (Med Eye) were included in this observational study. They received IDEEL and OSDI questionnaires, Tear Film Osmolarity (TFO), grading of conjunctival hyperemia, fluorescein tear break-up time (tBUT), grading of corneal staining and Schirmer test. Results: IDEEL and OSDI scores were 48 ± 38 and 11 ± 12, respectively, with moderate correlation (r = 0.50, p = 0.03). Compared with Med eyes, Trab Eyes had higher tBUT (6.5 ± 3.5 vs. 5.1 ± 2.7 s, p = 0.004), lower conjunctival hyperemia (0.8 ± 0.9 and 1.7 ± 1.1 respectively, p < 0.001) and lower corneal staining (0.3 ± 0.5 and 0.6 ± 0.5, respectively, p = 0.03). Correlation between corneal staining and conjunctival hyperemia was 0.55 in Trab Eyes (p = 0.01) and 0.44 in Med Eyes (p > 0.05). Patients with bilateral corneal staining had had threefold worse questionnaire scores (p < 0.05). The duration of treatment and the daily exposure to preservatives did not directly affect OS parameters in this cohort of patients. Conclusions: Patients receiving successful trabeculectomy showed better OS homeostasis (higher TBUT, lower grading of conjunctival hyperemia and corneal staining) than fellow medically treated eyes. Presence of corneal epithelial damage in both eyes is the factor more consistently affecting questionnaire scores.

Citing Articles

Ocular Surface Evaluation after Switch from Latanoprost 0.005% to Latanoprostene Bunod 0.024.

Zanutigh V, Galetto L, Valvecchia F, Logioco C J Curr Glaucoma Pract. 2024; 17(4):205-209.

PMID: 38269264 PMC: 10803279. DOI: 10.5005/jp-journals-10078-1422.


Managing the ocular surface after glaucoma filtration surgery: an orphan topic.

Agnifili L, Figus M, Sacchi M, Oddone F, Villani E, Ferrari G Graefes Arch Clin Exp Ophthalmol. 2023; 262(7):2039-2056.

PMID: 38091058 DOI: 10.1007/s00417-023-06333-5.


Glaucoma and Dry Eye Disease: Opportunity to Assess and Treat.

Nijm L, Schweitzer J, Gould Blackmore J Clin Ophthalmol. 2023; 17:3063-3076.

PMID: 37869041 PMC: 10590113. DOI: 10.2147/OPTH.S420932.


Special Issue "Recommendations for Clinical Management of Glaucoma".

Fogagnolo P J Clin Med. 2022; 11(6).

PMID: 35329829 PMC: 8952424. DOI: 10.3390/jcm11061499.

References
1.
Agnifili L, Brescia L, Oddone F, Sacchi M, DUgo E, Di Marzio G . The ocular surface after successful glaucoma filtration surgery: a clinical, in vivo confocal microscopy, and immune-cytology study. Sci Rep. 2019; 9(1):11299. PMC: 6683151. DOI: 10.1038/s41598-019-47823-z. View

2.
Ranno S, Fogagnolo P, Rossetti L, Orzalesi N, Nucci P . Changes in corneal parameters at confocal microscopy in treated glaucoma patients. Clin Ophthalmol. 2011; 5:1037-42. PMC: 3151567. DOI: 10.2147/OPTH.S22874. View

3.
Lee S, Wong T, Chua J, Boo C, Soh Y, Tong L . Effect of chronic anti-glaucoma medications and trabeculectomy on tear osmolarity. Eye (Lond). 2013; 27(10):1142-50. PMC: 3806558. DOI: 10.1038/eye.2013.144. View

4.
Kurna S, Acikgoz S, Altun A, Ozbay N, Sengor T, Olcaysu O . The effects of topical antiglaucoma drugs as monotherapy on the ocular surface: a prospective study. J Ophthalmol. 2014; 2014:460483. PMC: 4070470. DOI: 10.1155/2014/460483. View

5.
. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007; 5(2):75-92. DOI: 10.1016/s1542-0124(12)70081-2. View